← Open Payments lookup

LISA KATULIS: Open Payments

NPI 1639715998 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$388 in 16 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $484 · 2025 $388

Food & beverage: $388
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP5$129
Bayer Healthcare Pharmaceuticals Inc.2$57
Gilead Sciences, Inc.2$47
ABBVIE INC.1$32
Merck Sharp & Dohme LLC2$29
TerSera Therapeutics LLC1$28
SpringWorks Therapeutics, Inc.1$25
Lilly USA, LLC1$23
Daiichi Sankyo Inc.1$19

Products named: ELAHERE, Nubeqa, Stivarga, Xermelo, KEYTRUDA.

Industry payments across MD — which companies pay providers there.